BillionaireNet
Juneja
Rajeev Juneja
Rank #1477
INDIAHealthcarePhamaceuticals

Rajeev Juneja

Net Worth
$2.708B
+1.44% (24h)
Rajeev Juneja, co-founder and Vice Chairman and Managing Director of Mankind Pharma, is a prominent figure in the Indian pharmaceutical industry. With a current net worth of $2.9 billion, he has significantly contributed to the healthcare sector. His journey, marked by a college dropout status, showcases his entrepreneurial drive and his leadership has been instrumental in making Mankind Pharma one of India's leading pharmaceutical companies. He is known for fostering a strong team environment and his focus on affordable medicines.

The Full Dossier

Early Life

Rajeev Juneja was born on July 28, 1965, in Delhi, India. He attended college but did not complete his degree, opting instead to gain practical experience in the pharmaceutical industry. This early decision reflects his entrepreneurial spirit and determination to build a successful career.

Rise to Success

In 1991, Rajeev Juneja co-founded Mankind Pharma with his elder brother, Ramesh Juneja. Starting with a modest investment of ₹50 lakh, the company began active operations in 1995. Under his leadership as Vice Chairman and Managing Director, Mankind Pharma has grown to become a major player in the Indian pharmaceutical market, known for its diverse product range including Manforce condoms and Prega News pregnancy test kits. The company has a strong market presence in both the OTC and FMCG segments.

Key Business Strategies

Rajeev Juneja's leadership has been characterized by his focus on building strong teams and fostering a dynamic work environment. His mantra of 'staying dynamic' and maintaining a 'startup culture' has been crucial to the company's rapid growth. He emphasizes the importance of understanding the needs of employees and providing them with opportunities for growth. This approach has enabled Mankind Pharma to maintain a competitive edge and expand into new sectors, including agritech and pet care.

Philanthropy

During the COVID-19 pandemic, Rajeev Juneja's company donated ₹250 crore for relief efforts. He believes in the importance of compassion and instills this value within his company culture, emphasizing the importance of supporting employees and their families during difficult times.

Career Timeline

2024

Acquisition of Bharat Serums and Vaccines

Mankind Pharma acquired Bharat Serums and Vaccines for approximately ₹13,630 crore.

2023

Mankind Pharma IPO

Mankind Pharma went public, marking a significant milestone.

1995

Mankind Pharma Operations Started

Mankind Pharma began active operations.

1991

Co-founded Mankind Pharma

Rajeev Juneja, along with his brother Ramesh Juneja, founded Mankind Pharma as a private company.

Philanthropic Impact

Disaster Relief$30.1M

COVID-19 Relief

Mankind Pharma donated ₹250 crore for relief during the COVID-19 pandemic.

Wealth Trajectory